A Randomized, Sham Controlled, Multicenter, Double-Masked, Phase 2/3 Study Assessing Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion
Sponsor study identifier
interventional
N/A
2 countries
2
Study Start
Not reported
Date not reportedPrimary Completion
Not reported
Date not reportedStudy Completion
Not reported
Date not reportedThis study will evaluate the efficacy and safety of Betamethasone Microsphere (DE-102) for macular edema following branch retinal vein occlusion
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 15, 2012
Actual (reported)January 19, 2012
Actual (reported)Change from baseline of Best Corrected Visual Acuity(BCVA) in ETDRS letter score
Change in retinal thickness from baseline
Santen study sites
Osaka, Japan
Santen study sites
Seoul, South Korea
First Submitted
January 15, 2012
First Posted
January 19, 2012
Last Updated
July 21, 2014
Record last verified: 2014-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved:
Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.